 - Using simulation modeling that is directly informed by the data obtained from this study, determine the cost-effectiveness expressed as cost per infection detected and cost per year of life gained of 1 routine, universal screening and 2 risk factor-directed screening of newly diagnosed cancer patients for HIV, HBV, andor HCV vs. current care. 